ASCO 2017: Practice-Changing Studies on Metastatic Hormone-Sensitive Prostate Cancer
Aly-Khan Lalani, MD of Dana-Farber Cancer Institute gives an overview of practice-changing data coming out of ASCO on metastatic hormone-sensitive prostate cancer. This was recorded at the 2017 ASCO A...
Author: ASCO2017
Added: 06/14/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 14, 2017 Category: Cancer & Oncology Source Type: podcasts
Longevity of Ovarian Function and Risk for Heart Failure
Dr Andrew Kaunitz discusses hormone receptor therapy in menopausal women and the relationship between ovarian function duration and risk for heart failure. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - June 8, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Longevity of Ovarian Function and Risk for Heart Failure
Dr Andrew Kaunitz discusses hormone receptor therapy in menopausal women and the relationship between ovarian function duration and risk for heart failure. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - June 8, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts
ARASENS: Darolutamide for Men with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Mark Rutstein, Vice President of Oncology Development of Bayer gives an overview of the ARASENS study, which is a phase 3 trial on the use of darolutamide for men with metastatic hormone-sensitive pro...
Author: ASCO2017
Added: 06/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2017 Category: Cancer & Oncology Source Type: podcasts
Oxytocin and the Biology of Love: Too Much of a Good Thing?
Can exogenous use of the ' love hormone ' be disruptive? It ' s possible, says biologist and oxytocin researcher Dr Sue Carter. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - May 9, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts
How did CHAARTED and STAMPEDE impact your treatment of metastatic hormone sensitive prostate cancer patients?
Neal D. Shore, MD, FACS of Carolina Urologic Research Center discusses how CHAARTED and STAMPEDE impacted his treatment for patients with metastatic hormone sensitive prostate cancer at the 2017 Genit...
Author: obr
Added: 03/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 1, 2017 Category: Cancer & Oncology Source Type: podcasts
Menopausal Hormone Therapy and Alzheimer Disease Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
CHAARTED and STAMPEDE Impacting Treatment for Metastatic Hormone Sensitive Prostate Cancer Patients
Ana Aparicio, MD of MD Anderson Cancer Center discusses how the CHARTED and STAMPEDE trials impacted her treatment for patients with metastatic hormone sensitive prostate cancer at the 2017 Genitourin...
Author: obr
Added: 02/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Amer Diab Core Update Feb 2017
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 15 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - January 24, 2017 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
An Update on Hormonal Therapy for Advanced Prostate Cancer
Are there recent advances in treating advanced prostate cancer patients with hormonal therapy? Listen as a panel of experts, including Dr. Tomasz Beer, Dr. Russell Szmulewitz, Dr. Emmanuel Antonarakis...
Author: patientpower
Added: 09/08/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 8, 2016 Category: Cancer & Oncology Source Type: podcasts
An Overview of Hormonal Therapy Options for Advanced Prostate Cancer
Expert Dr. Russell Szmulewitz of the University of Chicago Medical Center describes the endocrinology of prostate cancer and provides an overview of hormonal therapies. Dr. Szmulewitz examines the cha...
Author: P2Professional
Added: 06/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2016 Category: Cancer & Oncology Source Type: podcasts
